Philipp Ellmerer

Dr. Philipp Ellmerer

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2020 in Cancers
Verified
Journal Article
Open access
PDF file
FPFlorian Primavesi
Florian Primavesi
VAValentina Andreasi
Valentina Andreasi
FHFrederik J.H. Hoogwater
Frederik J.H. Hoogwater
SPStefano Partelli
Stefano Partelli
DWDominik Wiese
Dominik Wiese
SSStefan Stättner
Stefan Stättner
Background: Oncological survival after resection of pancreatic neuroendocrine neoplasms (panNEN) is highly variable depending on various factors. Risk stratification with preoperatively available parameters could guide decision-making in multidisciplinary treatment concepts. C-reactive Protein (CRP) is linked to inferior survival in several malignancies. This study assesses CRP within a novel risk score predicting histology and outcome after surgery for sporadic non-functional panNENs. Methods: A retrospective multicenter study with national exploration and international validation. CRP and other factors associated with overall survival (OS) were evaluated by multivariable cox-regression to create a clinical risk score (CRS). Predictive values regarding OS, disease-specific survival (DSS), and recurrence-free survival (RFS) were assessed by time-dependent receiver-operating characteristics. Results: Overall, 364 patients were included. Median CRP was significantly higher in patients >60 years, G3, and large tumors. In multivariable analysis, CRP was the strongest preoperative factor for OS in both cohorts. In the combined cohort, CRP (cut-off ≥0.2 mg/dL; hazard-ratio (HR):3.87), metastases (HR:2.80), and primary tumor size ≥3.0 cm (HR:1.83) showed a significant association with OS. A CRS incorporating these variables was associated with postoperative histological grading, T category, nodal positivity, and 90-day morbidity/mortality. Time-dependent area-under-the-curve at 60 months for OS, DSS, and RFS was 69%, 77%, and 67%, respectively (all p < 0.001), and the inclusion of grading further improved the predictive potential (75%, 84%, and 78%, respectively). Conclusions: CRP is a significant marker of unfavorable oncological characteristics in panNENs. The proposed internationally validated CRS predicts histological features and patient survival.

19 May 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
PEPhilipp Ellmerer
Philipp Ellmerer
MPMarina Peball
Marina Peball
FCFederico Carbone
Federico Carbone
MRMarcel Ritter
Marcel Ritter
BHBeatrice Heim
Beatrice Heim
KSKlaus Seppi
Klaus Seppi
The topic of the therapeutic use of cannabinoids in Parkinson’s disease (PD) is broadly discussed and frequently comes up in the outpatient clinic. So far, there are only a few randomized clinical trials assessing the effects of cannabinoids in PD. We are able to demonstrate a reduction in non-motor symptom (NMS) burden after the administration of nabilone. As impairment of attention and working memory have been described earlier as possible side effects, we assess cognitive performance using saccadic paradigms measured by an eye tracker. We do not observe a significant difference in any of the saccadic paradigms between PD patients on placebo versus those treated with nabilone. We, therefore, conclude that top-down inhibitory control is not affected by the tetrahydrocannabinol analogue. Nabilone did not significantly worsen cognitive performance and appears to be safe to use in selected PD patients who suffer from disabling NMS.

20 October 2022 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
FCFederico Carbone
Federico Carbone
LZLaura Zamarian
Laura Zamarian
VRVerena Rass
Verena Rass
SBStefanie Bair
Stefanie Bair
MRMarcel Ritter
Marcel Ritter
RHRaimund Helbok
Raimund Helbok
Increasing evidence suggests persistent cognitive dysfunction after COVID‐19. In this cross‐sectional study, frontal lobe function was assessed 12 months after the acute phase of the disease, using tailored eye tracking assessments. Individuals who recovered from COVID‐19 made significantly more errors in all eye tracking tasks compared to age/sex‐matched healthy controls. Furthermore, patients who were treated as inpatients performed worse compared to outpatients and controls. Our results show impaired inhibitory cortical control in individuals who recovered from COVID‐19. The association between disease severity and its sequelae may contribute to a better understanding of post‐COVID‐19 cognitive function.

12 August 2020 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
PEPhilipp Ellmerer
Philipp Ellmerer
BHBeatrice Heim
Beatrice Heim
ASAmbra Stefani
Ambra Stefani
MPMarina Peball
Marina Peball
MWMario Werkmann
Mario Werkmann
ADAtbin Djamshidian
Atbin Djamshidian
Objective: To assess emotional processing and alexithymia in patients with restless legs syndrome (RLS) with augmentation versus those who never had augmentation.Methods: We recruited 26 patients who had a history of augmentation (AUG), either current or past, 27 RLS patients treated with dopamine agonists who never had augmentation (RLS controls), and 21 healthy controls (HC). All participants were screened for impulse control disorders (ICDs). Alexithymia was assessed by means of the Toronto Alexithymia Scale – 20 (TAS‐20). Facial emotion recognition was tested through an eye‐tracking task. Furthermore, all participants performed neuropsychological tests assessing global cognitive status, impulsivity, anxiety, and depression.Results: ICD symptoms occurred more frequently in AUG patients than in RLS controls (P = 0.047). Patients with AUG scored higher on the TAS‐20 (P = 0.007) and the attentional subdomain of an impulsivity scale (BIS‐11; P = 0.015) compared to HC. Patients with AUG also performed worse on the facial emotion recognition task relative to RLS controls (P = 0.009) and HC (P = 0.003). We found a group difference for the time to first fixation and the fixation count in the mouth region (P = 0.019 and P = 0.021, respectively). There were no other differences in the eye tracking examination.Interpretation: This study showed evidence of poorer emotional processing in patients who had augmentation compared to RLS patients without augmentation and healthy controls. The altered exploration pattern of faces and the higher alexithymia scores suggest abnormalities in emotion processing in patients with augmentation.

17 March 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
BHBeatrice Heim
Beatrice Heim
PEPhilipp Ellmerer
Philipp Ellmerer
Ambra StefaniAmbra Stefani
Ambra Stefani
AHAnna Heidbreder
Anna Heidbreder
EBElisabeth Brandauer
Elisabeth Brandauer
ADAtbin Djamshidian
Atbin Djamshidian
Background: Augmentation (AUG) in patients with restless legs syndrome (RLS) can be associated with impulse control disorder (ICD) symptoms, such as compulsive sexual behavior, gambling disorder or compulsive shopping. In this study, we wanted to assess whether RLS patients with AUG differ in decision making from those patients who have augmentation and in addition ICD symptoms (AUG + ICD) in a post hoc analysis of a patient cohort assessed in a previous study. Methods: In total, 40 RLS patients with augmentation (19 AUG + ICD, 21 AUG without ICDs) were included. RLS diagnosis, severity, and diagnosis of augmentation were made by sleep disorder specialists. ICD symptoms were assessed using semi-structured interviews. All patients performed the beads task, which is an information sampling task where participants must decide from which of the two cups colored beads were drawn. Results were compared to 21 healthy controls (HC). Results: There was no difference in information sampling or irrational decision making between AUG and AUG + ICD patients (p = 0.67 and p = 1.00, respectively). Both patient groups drew less beads and made more irrational decisions than HC (all p-values < 0.03, respectively). Conclusions: Our results suggest that augmentation itself is associated with poorer decision making even in the absence of ICD symptoms. Further studies are necessary to explore whether rapid and hasty decision making are a harbinger of augmentation in RLS.

1 November 2020 in Sleep Medicine
Verified
Journal Article
Closed access
PEPhilipp Ellmerer
Philipp Ellmerer
Ambra StefaniAmbra Stefani
Ambra Stefani
BHBeatrice Heim
Beatrice Heim
MBMelanie Bergmann
Melanie Bergmann
KSKlaus Seppi
Klaus Seppi
ADAtbin Djamshidian
Atbin Djamshidian